These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 22820191)

  • 21. MicroRNA-622 functions as a tumor suppressor by targeting K-Ras and enhancing the anticarcinogenic effect of resveratrol.
    Han Z; Yang Q; Liu B; Wu J; Li Y; Yang C; Jiang Y
    Carcinogenesis; 2012 Jan; 33(1):131-9. PubMed ID: 22016468
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNA-21 stimulates gastric cancer growth and invasion by inhibiting the tumor suppressor effects of programmed cell death protein 4 and phosphatase and tensin homolog.
    Li L; Zhou L; Li Y; Lin S; Tomuleasa C
    J BUON; 2014; 19(1):228-36. PubMed ID: 24659669
    [TBL] [Abstract][Full Text] [Related]  

  • 23. miR-143 inhibits the metastasis of pancreatic cancer and an associated signaling pathway.
    Hu Y; Ou Y; Wu K; Chen Y; Sun W
    Tumour Biol; 2012 Dec; 33(6):1863-70. PubMed ID: 23070684
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthetic miR-143 Inhibits Growth of HER2-Positive Gastric Cancer Cells by Suppressing KRAS Networks Including DDX6 RNA Helicase.
    Tokumaru Y; Tajirika T; Sugito N; Kuranaga Y; Shinohara H; Tsujino T; Matsuhashi N; Futamura M; Akao Y; Yoshida K
    Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30959742
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting EphA2 with miR-124 mediates Erlotinib resistance in K-RAS mutated pancreatic cancer.
    Du J; He Y; Wu W; Li P; Chen Y; Hu Z; Han Y
    J Pharm Pharmacol; 2019 Feb; 71(2):196-205. PubMed ID: 30604411
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A miR-29b Byproduct Sequence Exhibits Potent Tumor-Suppressive Activities via Inhibition of NF-κB Signaling in
    Inoue A; Mizushima T; Wu X; Okuzaki D; Kambara N; Ishikawa S; Wang J; Qian Y; Hirose H; Yokoyama Y; Ikeshima R; Hiraki M; Miyoshi N; Takahashi H; Haraguchi N; Hata T; Matsuda C; Doki Y; Mori M; Yamamoto H
    Mol Cancer Ther; 2018 May; 17(5):977-987. PubMed ID: 29545333
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effective suppression of the Kirsten rat sarcoma viral oncogene in pancreatic tumor cells via targeted small interfering RNA delivery using nanoparticles.
    Zeng L; Li J; Li J; Zhang Q; Qian C; Wu W; Lin Z; Liang J; Chen Y; Huang K
    Pancreas; 2015 Mar; 44(2):250-9. PubMed ID: 25401377
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rasfonin, a novel 2-pyrone derivative, induces ras-mutated Panc-1 pancreatic tumor cell death in nude mice.
    Xiao Z; Li L; Li Y; Zhou W; Cheng J; Liu F; Zheng P; Zhang Y; Che Y
    Cell Death Dis; 2014 May; 5(5):e1241. PubMed ID: 24853419
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oncogenic KRAS regulates miR-200c and miR-221/222 in a 3D-specific manner in colorectal cancer cells.
    Tsunoda T; Takashima Y; Yoshida Y; Doi K; Tanaka Y; Fujimoto T; Machida T; Ota T; Koyanagi M; Kuroki M; Sasazuki T; Shirasawa S
    Anticancer Res; 2011 Jul; 31(7):2453-9. PubMed ID: 21873159
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MDA-7/IL-24 regulates the miRNA processing enzyme DICER through downregulation of MITF.
    Pradhan AK; Bhoopathi P; Talukdar S; Scheunemann D; Sarkar D; Cavenee WK; Das SK; Emdad L; Fisher PB
    Proc Natl Acad Sci U S A; 2019 Mar; 116(12):5687-5692. PubMed ID: 30842276
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA miR-183 functions as an oncogene by targeting the transcription factor EGR1 and promoting tumor cell migration.
    Sarver AL; Li L; Subramanian S
    Cancer Res; 2010 Dec; 70(23):9570-80. PubMed ID: 21118966
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oridonin inhibition and miR‑200b‑3p/ZEB1 axis in human pancreatic cancer.
    Gui Z; Luo F; Yang Y; Shen C; Li S; Xu J
    Int J Oncol; 2017 Jan; 50(1):111-120. PubMed ID: 27878247
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CyclinD1 inhibits dicer and crucial miRNA expression by chromatin modification to promote the progression of intrahepatic cholangiocarcinoma.
    Qi Y; Wang D; Huang W; Wang B; Huang D; Xiong F; Chen X; Chen Y
    J Exp Clin Cancer Res; 2019 Oct; 38(1):413. PubMed ID: 31590696
    [TBL] [Abstract][Full Text] [Related]  

  • 34. microRNA-18a, a member of the oncogenic miR-17-92 cluster, targets Dicer and suppresses cell proliferation in bladder cancer T24 cells.
    Tao J; Wu D; Li P; Xu B; Lu Q; Zhang W
    Mol Med Rep; 2012 Jan; 5(1):167-72. PubMed ID: 21935572
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MiR-377 reverses cancerous phenotypes of pancreatic cells via suppressing DNMT1 and demethylating tumor suppressor genes.
    Azizi M; Fard-Esfahani P; Mahmoodzadeh H; Fazeli MS; Azadmanesh K; Zeinali S; Teimoori-Toolabi L
    Epigenomics; 2017 Aug; 9(8):1059-1075. PubMed ID: 28758420
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutated K-ras activates CDK8 to stimulate the epithelial-to-mesenchymal transition in pancreatic cancer in part via the Wnt/β-catenin signaling pathway.
    Xu W; Wang Z; Zhang W; Qian K; Li H; Kong D; Li Y; Tang Y
    Cancer Lett; 2015 Jan; 356(2 Pt B):613-27. PubMed ID: 25305448
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MiR-221 Promotes Capan-2 Pancreatic Ductal Adenocarcinoma Cells Proliferation by Targeting PTEN-Akt.
    Yang W; Yang Y; Xia L; Yang Y; Wang F; Song M; Chen X; Liu J; Song Y; Zhao Y; Yang C
    Cell Physiol Biochem; 2016; 38(6):2366-74. PubMed ID: 27230035
    [TBL] [Abstract][Full Text] [Related]  

  • 38. RAS/ERK modulates TGFbeta-regulated PTEN expression in human pancreatic adenocarcinoma cells.
    Chow JY; Quach KT; Cabrera BL; Cabral JA; Beck SE; Carethers JM
    Carcinogenesis; 2007 Nov; 28(11):2321-7. PubMed ID: 17638924
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Silencing of miR-152 contributes to DNMT1-mediated CpG methylation of the PTEN promoter in bladder cancer.
    Liu P; Wu L; Chand H; Li C; Hu X; Li Y
    Life Sci; 2020 Nov; 261():118311. PubMed ID: 32861793
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In hepatocellular carcinoma miR-519d is up-regulated by p53 and DNA hypomethylation and targets CDKN1A/p21, PTEN, AKT3 and TIMP2.
    Fornari F; Milazzo M; Chieco P; Negrini M; Marasco E; Capranico G; Mantovani V; Marinello J; Sabbioni S; Callegari E; Cescon M; Ravaioli M; Croce CM; Bolondi L; Gramantieri L
    J Pathol; 2012 Jul; 227(3):275-85. PubMed ID: 22262409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.